title: Somatostatin-like immunoreactivity in CSF in schizophrenic patients during haloperidol treatment.
authors.affiliation: Vaajasalo Hospital, Kortejoki, Kuopio, Finland.
authors.forename: J
authors.initials: J
authors.lastname: Jolkkonen
authors.forename: A
authors.initials: A
authors.lastname: Pitkänen
authors.forename: P J
authors.initials: PJ
authors.lastname: Riekkinen
authors.forename: E R
authors.initials: ER
authors.lastname: Korpi
authors.forename: C A
authors.initials: CA
authors.lastname: Kaufmann
authors.forename: D R
authors.initials: DR
authors.lastname: Weinberger
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides; D012016:Reference Values; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D012565:Schizophrenic Psychology
chemical_list: D010455:Peptides; C029993:somatostatin-like peptides; D006220:Haloperidol